Principal investigators and laboratory researchers seeking to evaluate monocyte activity regulation, macrophage polarization, and pulmonary chromatin interaction can source high-purity Chonluten tripeptide directly from PX1 Research. Formulated strictly for in vitro assays and preclinical models, our synthetic Chonluten provides rigorous lot-to-lot consistency backed by third-party HPLC, mass spectrometry, and endotoxin analysis.
Principal investigators and laboratory researchers seeking to evaluate monocyte activity regulation, macrophage polarization, and pulmonary chromatin interaction can source high-purity Chonluten tripeptide directly from PX1 Research. Formulated strictly for in vitro assays and preclinical models, our synthetic Chonluten provides rigorous lot-to-lot consistency backed by third-party HPLC, mass spectrometry, and endotoxin analysis.
When purchasing synthetic tripeptides to analyze monocyte activity regulation, biological research laboratories require absolute peptide purity, verified sequence integrity, and ultra-low endotoxin levels. Chonluten (L-Glutamyl-L-Aspartyl-L-Glycine, or EDG) is a synthetic short-chain peptide studied extensively in preclinical models for its role in modulating chromatin structure, gene transcription, and macrophage inflammatory responses in bronchial and pulmonary tissues.
To purchase research-grade material for cellular assays, laboratories utilize PX1 Research to secure USA-manufactured compounds paired with batch-specific analytical documentation. Every batch undergoes reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS) at an independent ISO 17025 accredited testing facility to guarantee identity and quantitative purity prior to distribution.
Chonluten is a low-molecular-weight tripeptide comprising the amino acid sequence L-glutamic acid, L-aspartic acid, and glycine (Glu-Asp-Gly). Classified within the short bioregulatory peptide family, its structural simplicity enables rapid cellular penetration and targeted binding interactions within nuclear chromatin. In contrast to complex proteins, short peptide sequences exhibit high chemical stability during handling when properly lyophilized and preserved.
Researchers exploring gene transcription pathways often compare short oligopeptides across related cellular targets. The structural motif of Chonluten allows it to fit into the major and minor grooves of genomic DNA, specifically targeting promoter regions associated with structural proteins and immune regulatory cytokines. Researchers interested in broader peptide architecture can review our complete catalog of research peptides to compare structural properties across bioregulatory sequences.
Preclinical studies suggest that Chonluten regulates monocyte activity primarily through direct epigenomic interaction rather than membrane-bound receptor signaling. In vitro assays using cultured human blood monocytes and alveolar macrophages demonstrate that the EDG peptide permeates cellular and nuclear membranes to bind specific histone motifs and DNA sequences. This binding induces localized chromatin decondensation, enabling RNA polymerase access to targeted gene promoters.
Specifically, monocyte activity regulation by Chonluten involves modulating the transcription of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). In hyper-reactive macrophage models, exposure to Chonluten has been observed to downregulate hyperactive inflammatory transcription while normalizing endogenous antioxidant enzyme expression, including superoxide dismutase (SOD). Detailed mechanisms of short-chain genomic interactions are further explored in our analysis of tripeptide gene expression mechanisms.
The scientific literature regarding Chonluten focuses largely on preclinical pulmonary inflammation models and immune cell homeostasis. In animal models of acute lung injury and chronic bronchial hyper-responsiveness, administration of Chonluten demonstrated a marked reduction in neutrophil and monocyte infiltration into bronchoalveolar lavage fluid (BALF). The observed decrease in cellular recruitment corresponded with reduced parenchymal tissue damage and stabilized mucosal barrier integrity.
In vitro data indicate that when primary monocyte cultures are challenged with lipopolysaccharide (LPS), pre-incubation with Chonluten dampens the nuclear factor kappa B (NF-κB) signaling cascade. This reduction in NF-κB translocation helps regulate the transition of classical pro-inflammatory monocytes (M1 phenotype) toward an anti-inflammatory or tissue-repair phenotype (M2 phenotype). Investigators analyzing these inflammatory cascades can consult our centralized PX1 research library for updated preclinical abstracts and methodology references.
Understanding the specific experimental utility of Chonluten requires comparing its activity profile against structurally adjacent bioregulatory peptides. While Chonluten (Glu-Asp-Gly) specifically target monocyte-driven cytokine release and bronchial epithelial repair, other short peptides target distinct immune and cellular pathways. For instance, Bronchogen (Ala-Glu-Asp-Pro) targets tissue remodeling and DNA expression primarily within bronchial smooth muscle cells.
Similarly, Thymogen (Glu-Trp) acts predominantly on T-lymphocyte differentiation and systemic cell-mediated immunity rather than localized macrophage activation. While all three belong to the class of short peptide bioregulators, Chonluten exhibits superior targeted binding in monocyte activity assays focused on pulmonary air-tissue interfaces. The table below highlights key functional distinctions evaluated in preclinical literature:
Proper handling and solution preparation are critical to maintaining the structural integrity of lyophilized Chonluten during cell culture experiments. Chonluten is highly hydrophilic due to the presence of side-chain carboxylic acid groups on its glutamic and aspartic acid residues. It dissolves readily in standard laboratory buffers, including sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or balanced salt solutions.
For optimal long-term stability, lyophilized Chonluten vials should be stored at -20°C upon receipt. Once reconstituted into working stock solutions for cell culture assays, aliquots should be maintained at 4°C for short-term experimentation (under 48 hours) or stored at -80°C to prevent hydrolysis and micro-precipitation. Repeated freeze-thaw cycles must be avoided, as thermal fluctuations accelerate peptide cleavage and alter baseline concentration accuracy.
In published laboratory literature, in vitro concentrations of Chonluten typically range from 0.01 ng/mL to 100 ng/mL depending on the culture duration and primary cell type. When evaluating monocyte activity regulation, researchers typically introduce the peptide prior to or concurrently with inflammatory stimulators such as LPS or phorbol 12-myristate 13-acetate (PMA).
Assay endpoints generally evaluate cell surface marker expression (CD14, CD68, CD163) via flow cytometry, supernatant cytokine quantification via ELISA or multiplex bead assays, and gene expression changes via quantitative real-time PCR (qPCR). To maintain reproducibility across assay runs, researchers sourcing materials for high-throughput screening often establish standardized reagent pipelines through PX1 wholesale lab accounts.
Assay reproducibility in immunological research depends entirely on compound purity and supplier accountability. Impurities in synthetic peptide orders—such as residual trifluoroacetic acid (TFA), truncated peptide sequences, or heavy metal residues—can artifactually stimulate or inhibit monocyte activity, invalidating cell culture data.
PX1 Research enforces strict analytical verification standards for every lot of Chonluten. Each lot is accompanied by a downloadable, lot-specific Certificate of Analysis (COA) containing raw RP-HPLC chromatograms confirming sequence purity above 98.0%, alongside ESI-MS spectral data confirming precise molecular weight. Laboratories can verify lot integrity directly against our published analytical standards prior to initiating experimental runs.
Because monocyte activity regulation assays are exquisitely sensitive to bacterial endotoxins (lipopolysaccharides), purchasing research peptides with verified endotoxin limits is essential. Contaminating endotoxins in low-grade peptide batches can induce non-specific toll-like receptor 4 (TLR4) activation, completely obscuring the true regulatory effects of Chonluten.
PX1 Research performs chromogenic Limulus Amebocyte Lysate (LAL) testing on all lot batches destined for cellular and in vitro experimentation. Our synthetic Chonluten is verified to contain less than 0.01 EU/mg of endotoxin, ensuring that observed cellular responses, cytokine shifts, and transcriptional changes are attributable solely to the synthetic tripeptide rather than external bacterial contamination.
Research timelines demand reliable inventory management and prompt order fulfillment. PX1 Research maintains domestic US manufacturing compliance and operates dual distribution hubs located in California and Arizona to streamline logistics for academic, biotech, and pharmaceutical laboratories nationwide.
All orders placed before 3:00 PM EST, Monday through Friday, are dispatched standard same-day with temperature-controlled packaging options to prevent degradation during transit. By eliminating international customs bottlenecks and providing transparent batch tracking, PX1 Research serves as a dependable primary supplier for ongoing peptide research initiatives.
What is the amino acid sequence of Chonluten?
Chonluten is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and glycine, short-handed as Glu-Asp-Gly or EDG.
How does Chonluten regulate monocyte activity in laboratory models?
Preclinical studies demonstrate that Chonluten permeates nuclear membranes to interact directly with targeted chromatin sequences. This interaction modulates the transcription of key inflammatory cytokines (such as IL-1β, IL-6, and TNF-α) and helps regulate macrophage polarization under stimulated conditions.
What purity levels are provided with PX1 Research Chonluten?
Every lot of Chonluten supplied by PX1 Research is verified via RP-HPLC and ESI-MS to exceed 98.0% chemical purity, with batch-specific Certificates of Analysis available for download.
Why is endotoxin testing critical when evaluating monocyte activity?
Monocytes express high concentrations of TLR4 receptors that react strongly to trace bacterial endotoxins. Standardized LAL endotoxin testing (under 0.01 EU/mg) ensures that cellular activation observed in vitro is driven by the peptide rather than bacterial impurities.
What solvent is recommended for reconstituting Chonluten for in vitro assays?
Chonluten is highly soluble in aqueous media. It reconstitutes easily in sterile bacteriostatic water, sterile normal saline, or standard phosphate-buffered saline (PBS, pH 7.4).
How should Chonluten be stored to prevent peptide degradation?
Lyophilized vials should be kept sealed and stored at -20°C. Reconstituted stock solutions should be divided into single-use aliquots and stored at -80°C to minimize thermal degradation and prevent repeated freeze-thaw cycles.
How does Chonluten differ functionally from Bronchogen?
While both are bioregulatory short peptides targeting respiratory research models, Chonluten (Glu-Asp-Gly) focuses on monocyte and macrophage transcriptional regulation, whereas Bronchogen (Ala-Glu-Asp-Pro) targets epithelial cell repair and smooth muscle tissue stability.
Is Chonluten approved for clinical use or human administration?
No. Chonluten supplied by PX1 Research is strictly designated for laboratory research use, in vitro assays, and preclinical animal models. It is not for human, clinical, or therapeutic application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.